Specifically, it was the IDH1 mutant stable U87MG cells but not the mutant glioma tissue derived from patients that exhibited increased light chain 3 phosphatidylethanolamine conjugate (LC3-II) conversion. The gene discussed is MAP1LC3A; the disease is central nervous system cancer.